During the past decade, Hudklinikken Herning conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hudklinikken Herning" are "Psoriasis" (3 trials) and "Psoriasis Vulgaris" (1 trials). Many other conditions were trialed in "Hudklinikken Herning" in a lesser frequency.

Most popular intervention types in "Hudklinikken Herning" are "Drug" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "CP 690,550 10 mg" (1 trials), "CP 690,550 5 mg" (1 trials), "CP-690,550" (1 trials), "Etanercept 50 mg" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hudklinikken Herning" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hudklinikken Herning". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hudklinikken Herning, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hudklinikken Herning, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".